Clinical trial Recruiting at 6 sites Observational Ages 19 to 69

Ultrasound-guided Pharmacopuncture for Spinal Pain in Korea

Official title: Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases: A Multi-center, Registry Study

Run by Jaseng Medical Foundation · NCT07543692 · Data updated 2026-11-12

This registry follows patients with spinal pain to see if ultrasound-guided pharmacopuncture is safe and helps reduce pain.

More Low Back Pain trials

Quick facts

Study typeObservational
Ages19 Years to 69 Years
SexAll
Enrollment600 (estimated)
SponsorJaseng Medical Foundation
Academic / other
Locations6 sites (Daejeon, Daejeon and 5 other locations)
StatusRecruiting
StartedApril 29, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJuly 16, 2026
Trial IDNCT07543692 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 to under 70 with spinal disease and predominant pain (NRS ≥5) undergoing ultrasound-guided pharmacopuncture in routine care.

Probably not a fit

Patients whose pain does not improve or who experience adverse events from the intervention may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter registry study evaluating the safety and effectiveness of ultrasound-guided pharmacopuncture in adults with spinal disease. About 600 participants aged 19 to under 70 will be enrolled across six Korean medicine hospitals and followed during routine care. Data on pain, function, and quality of life will be collected at multiple time points to explore changes from baseline to 4 weeks and beyond. The treatment is chosen by clinicians as part of standard care, not mandated by the study. Primary outcomes focus on pain intensity, with secondary outcomes including disability indices and quality of life.

Why it matters

Potential benefit: If successful, the approach could provide evidence on a real-world option to reduce spinal pain and improve function.

How similar studies have gone: Previous observational data in related procedures suggest potential safety and symptom relief, but this specific ultrasound-guided pharmacopuncture approach is being evaluated in a real-world registry.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients diagnosed with spinal diseases (KCD codes M and S).
2. Patients whose Numeric Rating Scale (NRS) score for the most predominant pain (neck pain with upper limb radiating pain OR low back pain with lower limb radiating pain) caused by spinal diseases is 5 or higher.
3. Outpatients or inpatients scheduled to utilize an ultrasound scan during pharmacopuncture (the decision to perform ultrasound-guided pharmacopuncture is made according to the clinician's routine medical judgment, not for research purposes).
4. Patients who voluntarily agree to participate in the clinical study and sign the informed consent form.

Exclusion Criteria:

1. Patients who have difficulty completing the written informed consent form.
2. Women who are pregnant, planning to become pregnant, or breastfeeding.
3. Patients deemed inappropriate for study participation by the investigator due to severe underlying diseases (e.g., cancer or other malignant neoplasms) that may interfere with treatment effects or result interpretation.
4. Individuals who are deemed unsuitable for participation in the clinical study by the researcher.

Where it's running

  • Daejeon Jaseng Hospital of Korean Medicine
    Daejeon, Daejeon, South Korea
    Recruiting
  • Jaseng Hospital of Korean Medicine
    Seoul, Gangnam-gu, South Korea
    Recruiting
  • Bucheon Jaseng Hospital of Korean Medicine
    Bucheon-si, GGyeonggi-do, South Korea
    Recruiting
  • Kyung Hee University Korean Medicine Hospital
    Seoul, South Korea
    Recruiting
  • Kyung Hee University Hospital at Gangdong
    Seoul, South Korea
    Recruiting
  • School of Korean Medicine, Pusan National University
    Yangsan, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.